A Few Bright Spots In HCA Healthcare Inc (NYSE: HCA)

HCA Healthcare Inc (NYSE:HCA) currently has a daily average trading volume of 1.63M but it saw 920890 shares traded in last market. With a market cap of 91.04B USD, the company’s current market price of $378.44 came falling about -0.10 while comparing to the previous closing price of $378.81. In past 52 weeks, the stock remained buoying in the range of price level as high as $417.14 and as low as $289.98. In the recent trading on the day, stock has struck highest price mark of $376.96 while lowest mark touched by it was $382.275.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Robert W. Baird which downgraded the stock as “Neutral” in its note to investors issued on April 15, 2025, recommending a price target of $336 for it. Wells Fargo also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $400 and $320.

Over the week, HCA’s stock price is moving -1.97% down while it is 13.98% when we observe its performance for the past one month. Year-to-date it is 26.08% up and over the past year, the stock is showing an upside performance of 20.02%.

The company is expected to be releasing its next quarterly report on 2025-Apr-24, for which analysts forecasted an EPS of 6.27 while estimate for next year EPS is 25.34. In next quarter, company is expected to be making quarterly sales of $18.48B as analysts are expecting the sales for current fiscal year at $74.71B and seeing the company making $78.48B in sales next year. Moreover, analysts are in estimates of $18.48B for current-quarter revenue.

Currently, HCA Healthcare Inc’s total number of outstanding shares is 242.96M with 29.31% of that held by the insiders while 63.90% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 14.67%. It has a price to earnings ratio (P/E ratio) of 16.82 while having a 13.50 of forward P/E ratio. Stock’s beta reads 1.49. Stock has a price to sale or P/S ratio amounts to 1.27. Its return on asset (ROA) is 9.90% on average.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.